BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Drug Development

  Gilead Release: Zydelig In Combination With Ofatumumab Improves Progression-Free Survival In Previously-Treated Patients With Chronic Lymphocytic Leukemia

  June 1, 2015

   · 

  11 min read
• Business

  BioMed Realty Trust Sells King Of Prussia Property In Radnor To Penn Medicine For $35 Million

  June 1, 2015

   · 

  1 min read
• Pharm Country

  Advaxis, Inc. Announces FDA Clearance Of Investigational New Drug Application For Phase 2 Study Of ADXS-HPV And Incyte’s Epacadostat For The Treatment Of HPV-Associated Early Stage Cervical Cancer

  June 1, 2015

   · 

  8 min read
• Business

  Arch Therapeutics Initiates Research And Development Collaboration With CURAM Centre For Research In Medical Devices

  June 1, 2015

   · 

  5 min read
• Drug Development

  Halozyme Therapeutics, Inc. Phase 2 Clinical Study Of Investigational Drug PEGPH20 Shows Doubling Of Progression-free Survival And Improvement Trend In Overall Survival In High HA Metastatic Pancreatic Cancer Patients

  June 1, 2015

   · 

  7 min read
• Genetown

  SCIEX And Metabolon Launch The Lipidyzer Platform For Complete Lipid Analysis, From Sample To Biology

  June 1, 2015

   · 

  1 min read
• Genetown

  Royal Philips Electronics N.V. Showcases MR Research Solutions Designed To Enable Collaboration With Partners At The ISMRM Annual Meeting

  June 1, 2015

   · 

  3 min read
• BioMidwest

  Alzheimer’s Association Release: New Research Summary: Lifestyle Changes Help Reduce Risk Of Cognitive Decline

  June 1, 2015

   · 

  5 min read
• Drug Development

  ASCO15: Biothera Presents Additional Data At ASCO On Durability And Characteristics Of Response With Imprime PGG In Non-Small Cell Lung Cancer Study

  June 1, 2015

   · 

  2 min read
• Drug Development

  Integrated Safety Data From Two Phase 2 Cancer Studies Demonstrates Biothera’s Investigational Cancer Immunotherapy Is Well Tolerated

  June 1, 2015

   · 

  2 min read